Literature DB >> 3266831

Correlation between B-cell mitogenicity and immunosuppressor effects of a protein released by porcine monocytes infected with African swine fever virus.

M P Arala-Chaves1, A dos S Ribeiro, M Vilanova, M T Porto, M G Santarem, M Lima.   

Abstract

Virus-free supernatants of cultured swine monocytes infected by African swine fever virus (ASFV) suppressed in vitro proliferation of porcine and human blood mononuclear cells in response to phytohemagglutinin and the in vivo primary immune response of C57BL/6 mice against sheep RBC. The supernatants were fractionated by discontinuous ion-exchange chromatography and subfractionated by double-step preparative isoelectric focusing. The pool of the most purified active subfractions (F5'EP-ASFV) is made up of heat-unstable material, can be stained by silver nitrate, and has an isoelectric point of 3.88, a maximal optical density at 280 nm, and a mass of 36,000 daltons. In vivo kinetic studies in nonimmunized C57BL/6 mice were performed on days 1, 2, 3, 5, and 7 after injection with 50 micrograms of F5'EP-ASFV protein. Compared with the untreated mice, the treated mice had a noticeable increase in nonspecific immunoglobulin-secreting splenic plaque-forming cells (PFC) with the following isotype profile: IgG2a greater than IgG2b greater than IgG3 greater than IgG1 congruent to IgM. Three days after treatment with the active material, specific IgM PFC against sheep RBC increased up to 23-fold. In C57BL/6 mice immunized against sheep RBC 2 days after treatment with F5'EP-ASFV, the increase in nonspecific PFC was followed by a suppression of specific PFC response in the respective isotype. When C57BL/6 mice were treated after priming with sheep RBC, however, there was little or no suppression of specific PFC and the increase in nonspecific PFC was considerably lower than that in the other F5'EP-ASFV-treated mice. In this case, kinetic curves of specific vs nonspecific PFC of each isotype were mirror images. Mice treated with 200 micrograms of F5'EP-ASFV protein died with hemorrhagic diastasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266831

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory protein.

Authors:  Isabel Veiga-Malta; Margarida Duarte; Márcia Dinis; Pedro Madureira; Paula Ferreira; Arnaldo Videira
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

2.  Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.

Authors:  M Lima; A Bandeira; D Portnoi; A Ribeiro; M A Chaves
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Changes in swine macrophage phenotype after infection with African swine fever virus: cytokine production and responsiveness to interferon-gamma and lipopolysaccharide.

Authors:  J T Whittall; R M Parkhouse
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  The biological effects induced in mice by p36, a proteinaceous factor of virulence produced by African swine fever virus, are mediated by interleukin-4 and also to a lesser extent by interleukin-10.

Authors:  M Vilanova; P Ferreira; A Ribeiro; M Arala-Chaves
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

Review 5.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Mycobacteria-induced autoantibody production is associated with susceptibility to infection but not with host propensity to develop autoimmune disease.

Authors:  A Brás; A P Aguas
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

7.  Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host.

Authors:  D Tavares; A Salvador; P Ferreira; M Arala-Chaves
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.